MD Anderson Cancer Center Leukemia Group

Houston, Texas 77030

0 studies enrolling now · 1 studies all time

What they study most

Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Anemia, Refractory, With Excess of Blasts, Solid Tumors

Studies at this site

• Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies — Completed